Background: Lack of evidence about the external validity of discrete choice experiments (DCEs) is one of the barriers that inhibit greater use of DCEs in healthcare decision making.
Introduction
The discrete choice experiment (DCE) technique, originating from mathematical psychology, 1, 2 has been introduced in health economics to elicit preferences for health and healthcare. 3 The technique is mainstream in marketing, transport, and environmental economics, where it is used to predict individual and collective choices. 4, 5 Its application in healthcare has grown exponentially 6, 7 because the method is easy to apply and appears efficient. [8] [9] [10] [11] DCEs in health economics are commonly used for valuing health and nonhealth outcomes, investigating trade-offs between health and nonhealth outcomes, and developing priority setting frameworks. 12 Nevertheless, there are also several other areas of applications, for example, DCEs can be used alongside measuring health and nonhealth benefits such as for model parameterization 13 and predicting uptake where there is no information. 14 Currently, among other barriers, the lack of evidence about the external validity of DCEs inhibits greater use of DCEs in healthcare decision making. External validity of DCE is defined as whether individuals behave in reality as they state in a hypothetical context. 3 Hence the question is "Are healthcare choices Conflicts of interest: None of the authors have competing interests. predictable?" To support claims based on DCEs for decision making in clinical or policy contexts, external validity is recognized as an important research question. 6, 7, 12 Although a DCE may succeed in demonstrating internal validity (eg, how accurately preferences are measured, the extent to which the results are consistent with a priori expectations, and the extent to which the DCE takes account of all things deemed important in the construct's domain 15 ), [16] [17] [18] this does not guarantee external validity. 16, 19, 20 Only a handful of studies, mainly outside healthcare, have investigated the external validity of DCEs [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] ; these studies all focus on final outcomes only. 33 Nevertheless, the investigation of external validity should be much broader. 33 That is, where exactly do discrepancies arise when stated preferences (SPs) derived from DCE do not match revealed preferences (RPs)? Unraveling determinants of external validity allows researchers to improve design, execution, and analysis in DCE studies, providing for more accurate (ie, the degree to which SP values being measured are close to the true RP values) assessments of preferences.
An important starting point in unraveling determinants of external validity of DCEs is to focus on the role of the researcher who must decide on the DCE design and model specification. The aim of this article was to determine whether the number of alternatives in a DCE choice task should reflect the actual decision context, and how complex the choice model specification needs to be to predict the uptake of a healthcare intervention mimicking a real-world decision correctly at an aggregate and individual levels. As we focus on testing designs and models for conducting and analyzing DCE data and their ability to predict the uptake of healthcare choices, we should keep in mind that respondents in SP studies probably have a different amount of information about the healthcare interventions they are evaluating than would likely be the case in RP data. Therefore, in our study, we maintain the choice context constant (ie, both the DCE and "a stated choice task mimicking a real-world healthcare decision" separately asked in the survey are explicitly hypothetical). This means that in our study we did not set out to compare purely SPs to purely RPs, but rather we position our comparison somewhere in between. Thus, we present partly an internal validation and partly an external validation to the extent that hypothetical healthcare choices in the real healthcare context are a stronger test than using a holdout sample from the DCE. Using this approach, we can check whether DCE is able to predict a hypothetical situation representing a reallife choice, which is a minimal requirement for external validity (ie, if DCE fails here, external validity will fail as well). 33 
Methods
Six DCEs were used, which varied in (1) medical condition and (2) the number of alternatives per choice task. Participants were randomized to a study setting. The information we presented about the attributes and their levels was exactly the same as the Dutch national flyer and invitation that participants would receive from their general practitioner or the National Institute for Public Health and the Environment to keep information asymmetry between the hypothetical situation representing the actual decision and the actual decision as small as possible.
Conditions
Two medical conditions were considered: influenza vaccination and colorectal cancer (CRC) screening. These medical fields were chosen because (1) subjects face a real choice because they are not obliged to opt for vaccination or screening, which is vital to test the consistency between stated and actual choices; (2) the number of people facing this decision is large, contributing to the relevance and feasibility of the study; and (3) the decision problems involve different diseases and consequences, which is important for generalizability of the study findings. Approval for the study was obtained from the Medical Ethics Committee, Erasmus MC (MEC-2016-095).
Influenza vaccination
Elderly in the Netherlands, aged 60 years and older, have 2 options regarding influenza vaccination: to opt for vaccination or to opt out. To determine the attributes and levels for the influenza vaccination alternatives, literature, [34] [35] [36] [37] [38] interviews with experts in the field of influenza vaccination (n = 4), and 3 focus groups with patients aged 60 years and older from general practices (n = 21) were used (see de Bekker-Grob et al 39 for more details). Five attributes were determined as relevant for subjects to choose to vaccinate or not: vaccination effectiveness (levels: 20%, 40%, 60%, and 80%), risk of severe side effects (levels: 1, 10, and 100 in every million persons), risk of mild side effects (levels: 1, 3, and 5 in every 10 persons), protection duration (levels: 3, 6, and 12 months), and absorption time (levels: 2 and 4 weeks).
CRC screening
In the Netherlands, individuals aged 55 to 75 years have 2 options for CRC screening: to opt into or out of screening. To determine the attributes and levels for the CRC screening alternatives, literature, interviews with experts in the field of CRC screening (n = 3), and 3 focus groups with patients aged 55 to 75 years from general practices (n = 20) were used. Five attributes were determined as relevant for subjects to choose for CRC screening or not: screening effectiveness (levels: 20%, 40%, and 60%), risk of false-negative outcome (levels: 15%, 25%, and 35%), waiting time for fecal occult blood test results (levels: 1, 2, and 3 weeks), waiting time for colonoscopy follow-up test (levels: 2, 4, and 8 weeks), and frequency of the fecal occult blood test (levels: every year, every 2 years, and every 3 years).
DCE Design
Each medical condition had 3 study settings: DCE choice tasks with (1) 2 alternatives (ie, pairs), (2) 3 alternatives (ie, triples), and (3) both (ie, mixed). Of note, the DCE design with 2 alternatives was a better reflection of the actual decision for influenza vaccination and for CRC screening. In each DCE study, subjects were asked to consider all 2 or 3 alternatives in a choice task as realistic alternatives and to choose the alternative that appealed most to them. To maximize the D-efficiency of each DCE design while accommodating substantial respondent heterogeneity, Bayesian heterogeneous DCE designs 40 were used. That is, for all 6 DCE studies (ie, 2 medical conditions times 3 DCE studies [pairs, triples, and mixed]), we generated a heterogeneous DCE design consisting of 10 subdesigns; here, we used the Fortran programming language for computations. Each respondent was assigned 1 randomly selected subdesign containing 16 choice tasks. Together these subdesigns were optimal to estimate a multinomial logit (MNL) model, on the basis of a main-effects utility function with 2-way interactions between the attribute "effectiveness" and the other attributes. The prior preference information (attribute weights) as required for the efficient Bayesian optimization approach was obtained from best guess priors using expert judgment and updated for each of these 6 DCE studies after a pilot run of 100 respondents each.
The choice tasks of the 3 DCE studies of each condition were the following: (1) 16 DCE choice tasks with 2 vaccination/ screening alternatives or 1 vaccination/screening alternative and 1 opt-out option; (2) 16 DCE choice tasks with 2 vaccination/ screening alternatives and 1 opt-out option; and (3) 8 DCE choice tasks with 2 vaccination/screening alternatives followed by 8 DCE choice tasks with 2 vaccination/screening alternatives and 1 optout option.
Besides these 16 DCE choice tasks per DCE study and questions regarding respondents' characteristics, a choice task was added to the survey mimicking the real-world choice (see Appendix Figures A.1 and A.2 in Supplemental Materials found at https:// doi.org/10.1016/j.jval.2019.04.1924 for influenza vaccination and CRC screening, respectively); this additional choice task was placed after the first 8 DCE choice tasks. The choice task representing the real-world choice was kept constant among the DCE studies per condition.
Finally, at the end of the survey, the respondents were asked validated Likert-scale questions related to their decision style, 41 health literacy, 42, 43 and numeracy 44, 45 ; these decision-making skills were of interest on the basis of literature, expert opinions, and focus groups because they all were hypothesized to have an impact on vaccination or screening choices. The questionnaire ended with queries about the complexity and length of the questionnaire.
Sample Size and Recruitment
An online sample of 1419 individuals aged 60 years and older and 1421 individuals aged 55 to 75 years from the Dutch general population, nationally representative in terms of age, sex, education, and geographic region, was recruited for the vaccination and screening condition, respectively, via Survey Sampling International. Calculation of optimal sample sizes for a DCE is complicated because it depends on the true values of the unknown parameters estimated in the choice models. 46 Nevertheless, on the basis of our DCE design and pilot run, and using the sample size calculation of de Bekker-Grob et al, 47 a sample size of 1200 respondents per condition (hence 400 respondents per DCE study) is sufficient to reliably detect preference differences between attribute levels at the 5% significance level.
Choice Modeling
Almost without exception, researchers in the field of health economics have modeled their DCE data within a random utility theory framework. 6, 46, [48] [49] [50] Several random utility specifications have been used to analyze discrete choice data. 6, 51, 52 Each choice model has its set of features, which should fit best the research question. Because the aim of our study was to determine how complex the choice model (complexity is here defined as the capacity to reveal underlying preferences; the more "complex" the model, the more degrees of freedom and the higher the capacity to include certain effects) needs to be to predict a choice mimicking a real-world healthcare decision, we analyzed the DCE data in a systematic way: from a simpler (model A, Table 1 ) to more and more complex models (models B-D, Table 1 ). On the basis of common practice in health economics, 6,7 our starting point was the homogeneous preference, homoskedastic MNL (model A, Table 1) 48 :
As shown in Equation 1, the latent utility of an alternative i in a choice set C n (as presented to individual n) is decomposable into 2 additively separable parts: (1) a systematic (explainable) component specified as a function of the attributes of the alternatives V(X in , b) and (2) a random (unexplainable) component ε in representing stochastic variation in choices. The MNL model has 3 key properties: (1) error terms are assumed independent and identically extreme value type I distributed across observations (IID); (2) independence of irrelevant alternatives, resulting from (1); and (3) no unattributable preference heterogeneity. Such assumptions may be restrictive in describing human behavior, perhaps compromising the external validity of DCE results. Therefore, we started by first relaxing the IID assumption (heteroskedastic multinomial logit [HMNL]; model B, Table 1 ) followed by relaxing preference homogeneity with known (up to 21 observed) subject characteristic sources (HMNL1; model C, Table 1 ) and by taking randomness of the alternative specific constant (ASC) parameter capturing systematic preferences toward opting out into account (HMNL11; model D, Table 1 ). That is, in model D we aimed to explain heterogeneity by including subject characteristics and using choice responses to obtain individual conditional parameters (see later) to explain heterogeneity regarding the ASC (ie, a n ). In this way, we are able to distinguish explained heterogeneity from unexplained heterogeneity. Hence, the following choice processes with scale and/or preference heterogeneity and/or random opt-out utility were used (see Equations 2-5):
where a n ¼ a 1 qZ 1n 1 h n ;
(3)
The quantity a n is the ASC for opting out for vaccination/screening compared with opting in, Z 1 and Z 2 are 2 sets of subject characteristics, h n is a normally distributed random component in a n , and HEV is a heteroskedastic extreme value distribution with variance parameter m n . 53, 54 To use terminology common to discrete choice models, our full specification is a heteroskedastic error component model. 55, 56 For each DCE data set, we used this 4-step approach (models A-D) to determine the optimal utility function using the Pythonbiogeme software (Michiel Bierlaire, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland) 57, 58 and taking the best model fits into account on the basis of the Bayesian information criterion. For each DCE study, we first determined for the fixed choice task mimicking the real-world choice which proportion of the sample opted for vaccination or screening (ie, the observed uptake). Second, using the parameter values estimated from the DCE choice tasks, we determined for each DCE study the predicted vaccination/screening uptake on the basis of the 4 best-fitting choice models (ie, models A-D, Table 1 ). Finally, we determined to what extent the predicted uptake was in agreement with the observed uptake at an aggregate and individual levels using probability rules, mean values, and 95% confidence intervals, whereas at an individual level for model D conditional parameter estimates were taken into account as well. Regarding the latter, using the coefficients of model D, the Pythonbiogeme software, the conditional parameter approach of Train 59 and Revelt and Train, 60 and Excel (Hess 61 ), we were able to determine the ASCs per individual (ASC_i; hence, a n ). These ASC_i's were added to the data set as a variable, because if individuals have systematically different preferences, which are unrelated to observed characteristics, ignoring to address it can bias the estimates of the preference weights. The utility function of model D, incorporating the ASC_i's, was used to determine the utility weight for each individual for influenza vaccination in the choice task mimicking the real-world decision. Then, like models A to C, we first simulated the probabilities for each individual that he or she would opt for influenza vaccination. Second, we summarized the probabilities for influenza vaccination for respondents who opted for vaccination in the choice task mimicking the real-world decision. Third, we summarized the probabilities for no vaccination for respondents who opted out of influenza vaccination in the choice task mimicking the real-world decision. Finally, these probability scores were summarized, divided by the sample size, and multiplied by 100 to obtain the percentage of correctly predicted choices at an individual level. 62 The same procedure was followed for the CRC screening condition.
Results

Respondents
In total, 1429 and 1421 subjects were recruited to participate in the DCE studies concerning influenza vaccination and CRC screening, respectively. This resulted in 1261 (89%) and 1219 (86%) completes. In both conditions, there were no substantial differences between the 3 DCE designs regarding dropout rates or perceived burden (see Table 2 ).
Respondents of the vaccination condition had a mean age of 66 6 5 years, about 56% were men, and one-third had a lower educational level (see Appendix Approximately 75% of the respondents reported that they were in good health, 27% had experienced influenza (symptoms) last year, and 30% of the respondents mentioned that they had never been vaccinated against influenza. There were no significant differences between the 3 samples in respondents' characteristics, except for the variable sex. Approximately 73% of the respondents reported that they were in good health, 13% suffered from cancer, and 73% mentioned that they have experience with screening. There were no significant differences in respondents' characteristics across the 3 samples.
Model Fit and Parameters
In the context of influenza vaccination data and focusing on the sample of respondents who received 3 alternatives per choice task (ie, triples), for all 4 models, the directions of the coefficients of the vaccination attributes were consistent with our a priori hypotheses, which implies theoretical validity of the different models ( Table 3 ). The more complex/sophisticated the model, the better the model fit. There is a very large difference in model fit between the models that took preference heterogeneity into account versus the simpler models. Looking at the model with the best model fit (model D), all vaccination attributes influenced patients' decision behavior for influenza vaccination. There is evidence of substantial scale and preference heterogeneity. Regarding scale heterogeneity, older respondents were significantly less consistent (P=.010) in their choices (ie, more affected by random variation in utility 29 ). Regarding preference heterogeneity, 11 respondent characteristics were observed that explained the preference heterogeneity found (P,.050): age, sex, education, health literacy, numeracy, decision-making style, health state, having a chronic disease, general attitude to vaccination, having been vaccinated last year, and experience with side effects of vaccination. Model D was also the best-fit model for the vaccination sample of respondents who filled in the pairs or the mixed choice tasks (see Appendix Tables A.3 Respondents' characteristics that explained scale and preference heterogeneity differed between the 3 DCE vaccination samples. Nevertheless, 7 characteristics explained part of the observed scale and/or preference heterogeneity in all 3 DCE vaccination samples: sex, health literacy, numeracy, decision-making style, general attitude to vaccination, having a disease, and having been vaccinated last year.
In the context of CRC screening data, again focusing on the sample of respondents who received the DCE with triples, for all 4 models the directions of the coefficients of the screening attributes showed the expected signs and most of them were statistically significant (Table 4 ). Also in this sample, model D had the best model fit. Again substantial scale and preference heterogeneity were found.
Regarding scale heterogeneity, respondents who had a more deliberative decision style, lived alone, or had a higher level of numeracy were more consistent in their choices (P,.010). Regarding preference heterogeneity, 12 respondent characteristics were observed that explained the preference heterogeneity found (P,.050): age, sex, education, health literacy, numeracy, decisionmaking style, health state, general attitude toward screening, living alone, CRC history in family, screening experience, and having consulted a general practitioner last month. Model D was also the model with the best model fit for the screening sample of 
Are Healthcare Choices Predictable?
Irrespective of the number of alternatives per choice task, the choice to opt for influenza vaccination and CRC screening was correctly predicted by the DCE at an aggregate level if scale, preference heterogeneity, and a random opt-out utility were taken into account ( Table 5 and Table 6 respectively; model D). A similar phenomenon was seen for 4 of 6 DCE samples, if only scale and observed preference heterogeneity were taken into account (model C). For both medical conditions we found that a better model fit did not automatically mean better prediction (eg, HMNL vs MNL).
At an individual level, the choice for vaccination was predicted best using a heteroskedastic error component model that took into account observed preference heterogeneity through subject characteristics and unknown subject characteristic sources that systematically affect the preference for opting out (model D): 81.6%, 93.6%, and 88.7% of the individuals' choices were correctly predicted, using a DCE with 2 alternatives or 3 alternatives per choice task, or both, respectively. At an individual level, the choice for screening was also predicted best using model D: 91.2%, 97.1%, and 93.9% of the individuals' choices were correctly predicted, using pairs, triples, and mixed choice tasks, respectively. Overall, looking at the results of both surveys, using the 3 alternatives per choice task, a heteroskedastic error component model with observed preference heterogeneity, and conditional parameter estimates for the unobserved preference heterogeneity for opting out seemed to correctly predict choices mimicking real-world decisions in more than 93% of the respondents at an individual level. As we are getting high prediction success statistics with this rather noncomplex model, our objective is attained; there is no clear rationale for using more complex (ie, advanced) models here.
Discussion
This study showed that irrespective of the number of alternatives per choice task over the range tested, the choice mimicking a real-world decision to opt for influenza vaccination and CRC screening was correctly predicted by a DCE-based model at an aggregate level, if scale and preference heterogeneity were taken into account. At an individual level, using the 3 alternatives per choice task and a heteroskedastic error component model seemed to be most promising, correctly predicting in 93.6% and 97.1% of the cases for vaccination and screening, respectively. Five respondent characteristics consistently explained a part of the observed scale and/or preference heterogeneity: sex, numeracy skill, decision-making style, general attitude toward the health intervention of interest, and experience with the health intervention of interest. For the models and designs we used, our study showed that more than 93% of choices were correctly predicted at an individual level, giving a degree of confidence in the results and external validity of SP studies.
A healthcare DCE study of Mohammadi et al 63 found that their best model correctly predicted at an individual level in 83% of the participants, which is somewhat lower than our findings. The same study however showed that individual-specific coefficients reflected respondents' actual choices more closely compared with aggregate-level estimates, which agrees with our outcomes. Wright et al 64 mentioned that it is likely that if scale heterogeneity is unaddressed in a healthcare DCE, the results of such a study might be misleading. Our study confirmed that this is indeed the case, but additionally our results showed that if systematic preference heterogeneity is ignored, the results of healthcare DCE studies might be misleading as well.
Although 2 or 3 alternatives per DCE choice task, or both, all predicted well at an aggregate level, we recommend the use of the 3 alternatives per DCE choice task design (at least if an opt-out alternative is included). Literature outside healthcare already shows that more robust choice models can be constructed from the 3 alternatives per choice task design than from the 2 alternatives per choice task design. 65 In addition, our results showed that the 3 alternatives per choice task DCEs did not differ in dropout rates or perceived burden compared with our other DCE samples. Nevertheless, we found a slightly better prediction at an individual level in the case of the 3 alternatives per choice task design, probably because of a richer data set. Note that our results are conditional on the number of attributes used in our study; decisions involving more attributes should view our recommendations as indicative.
Our study also has several limitations. First, there is the issue of generalizability of our results. Although the results were based on 2 unlabeled DCE designs in different disease areas, further research is needed to determine whether our results hold in labeled DCE designs and other disease contexts. Second, because of the systematic approach we used starting from common practice in health economics, other choice models (eg, latent class model and mixed logit model) and ensemble analyses were not investigated. Further research is therefore recommended, although researchers should be cautious about overfitting their data. In addition, further research is recommended to see whether DCE holds its potential when predicting real-world decisions, because issues such as hypothetical bias and difference in amount of information may play an important role.
Conclusions
Our study shows that DCE models that take into account both scale and preference heterogeneity were better able to predict choices mimicking real-world decisions and performed best when 3 alternatives were presented to respondents. Patient characteristics such as sex, numeracy, decision-making style, general attitude toward the health intervention of interest, and experience with the health intervention of interest seem to play a crucial role in predicting healthcare choices. Further research is needed to determine whether this result remains in other contexts.
